Novo
-
USA
Novo Nordisk stock rises after Wegovy recommended by UK’s drug price regulator
Michael Siluk | UCG | Universal Images Group | Getty Images Novo Nordisk It rose as much as 4 percent…
Read More » -
USA
Novo Nordisk launches Wegovy subscription for GLP-1 obesity drugs
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk On Tuesday, Wegovy launched a multi-month…
Read More » -
USA
India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top
In this photo taken in Brussels, Belgium, on August 9, 2025, the Novo Nordisk logo is seen with tablets, capsules…
Read More » -
USA
FDA approves high dose version of Novo Nordisk’s obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
Read More » -
USA
Novo Nordisk failed to report deaths of weight-loss drug patients
Novo Nordisk, maker of the popular weight-loss drugs Ozempic and Wegovy, is under fire from the federal government for failing…
Read More » -
USA
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk It became the first company to produce the GLP-1 drug for weight loss and became the most valuable…
Read More » -
USA
Novo Nordisk to slash Wegovy, Ozempic U.S. list prices by up to 50%
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
Read More » -
USA
Novo Nordisk stock falls as weight loss drug fails to beat Eli Lilly
Novo Nordisk The stock fell 15% on Monday after it said its next-generation weight-loss drug failed to meet its core…
Read More » -
USA
Novo Nordisk faces defining year in the obesity drug market
Mike Doustdar, CEO of Novo Nordisk, speaks in the Oval Office during an event about weight loss drugs at the…
Read More » -
USA
Novo Resources flags antimony, gold, silver upside at Wyloo
Mike Spreadborough, co-chairman of Novo Resources Corp’s board of directors, spoke to Proactive about the company’s early-stage exploration success at…
Read More »